Phil Albinus is a former executive editor of Employee Benefit Adviser and Employee Benefit News.
For reprint and licensing requests for this article, click here.
More From Employee Benefit News
With healthcare costs jumping 9%, employers are shifting strategy
Employers face another steep rise in healthcare expenses in 2027, prompting a closer look at GLP-1 coverage, pharmacy spending and high-cost conditions.
How this nonprofit built award-worthy healthcare benefits
In addition to finding success with a self-funded model, an in-house program gives Fello's employees access to cost-free primary and urgent care.
Benefits Think The most practical healthcare innovation in America isn’t coming from Silicon Valley
Public sectors are approaching chronic disease support out of necessity, leading to benefits that build a stronger workforce.
Employers face a new GLP-1 question: Are the drugs worth it?
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
What Trump’s ‘Great Healthcare Plan’ means for drug costs and price transparency
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.